明天SAVA & AVXL 将补涨

估摸着会收复这两天大部分的跌幅，拭目以待，ymyd

B. Riley Raises Cassava Sciences' PT to $111 from $78 on Regulatory Tailwinds for Late-Stage AD Therapeutic, Keeps Buy Rating

BY MT Newswires
— 8:31 AM ET 06/23/2021